Patents expiring in 2040

US 10633363

EPAC1 activators as HIV latency reversal agents (LRA)

The Board of Regents of the University of Texas System · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2020131224

Methods for Synthesis of Radionuclide Complex

ADVANCED ACCELERATOR APPLICATIONS ITALY S R L [IT] · Granted Thu Apr 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

DE 202020000818

Mittel zur äußeren Pflege der Haut von Tieren, insbesondere von Pferden

CP PHARMA HANDELSGESELLSCHAFT MBH [DE] · Granted Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Sun Apr 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640501

Methods of preparing inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639303

Alkaloids and their preparation and application as anti-HSV-1 agents

OCEAN UNIVERSITY OF CHINA · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639330

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

Iovance Biotherapeutics, Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640493

Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

The Regents of the University of California · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640517

Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

Aurigene Discovery Technologies Limited · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640791

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

The Regents of the University of California · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640534

Therapeutically active compositions and their methods of use

Agios Pharmaceuticals, Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639278

Delivery of agents using metastable liposomes

LIPELLA PHARMACEUTICALS, INC. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640570

Chimeric antigen receptors, compositions, and methods

Regents of the University of Minnesota · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640571

Human monoclonal antibodies specific for glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640771

Compositions and methods for treating and preventing macular degeneration

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640770

Hepatitis D virus (HDV) iRNA compositions and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640566

Nucleic acid molecules encoding antibodies to the human glucagon receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640558

Anti-IL-25 antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640535

Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies

The Board of Regents of the University of Oklahoma · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640511

Hepatitis B antiviral agents

Enanta Pharmaceuticals, Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639360

Methods for treating hypophosphatemic disorders

Ultragenyx Pharmaceutical Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640485

Methods and compounds for restoring mutant p53 function

PMV PHARMACEUTICALS, INC. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10640487

Solid state forms of Nilotinib salts

Teva Pharmaceuticals USA, Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639350

Methods and pharmaceutical compositions for improving wound healing using CD24

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639375

Progesterone formulations

Compass Therapeutics LLC · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639383

Methods and compositions for engineering immunity

Sangamo Therapeutics, Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639348

Peptides with anti-cancer activity

IDP DISCOVERY PHARMA, S.L. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639277

Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma

The Board of Regents of the University of Texas System · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639357

Enzymes and methods for cleaving N-glycans from glycoproteins

The Regents of the University of California · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639308

sGC stimulators

Cyclerion Therapeutics, Inc. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639320

Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis

KOREA UNITED PHARM. INC. · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639302

Use of CDK9 inhibitors to reduce cartilage degradation

The Regents of the University of California · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639289

Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction

CHINA PHARMACEUTICAL UNIVERSITY · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10639272

Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

AR 113437

INHIBIDORES MITOCONDRIALES PARA EL TRATAMIENTO DE TRASTORNOS DE PROLIFERACIÓN

BASILEA PHARM INT AG [CH] · Granted Wed May 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3118090

COMPOSITIONS ET PROCEDES POUR EDITION DU GENOME A MEDIATION PAR NHEJ

CRISPR THERAPEUTICS AG [CH] · Granted Thu May 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10647697

Nrf2 activating compounds and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10647754

Stabilized single human CD4 domains and fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10647720

Pyrimido-pyridazinone compounds and methods of use thereof

Asana BioSciences, LLC · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10649053

Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices

The Regents of the University of California · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10646550

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10647964

Non-neuroinvasive viruses and uses thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10648001

Method of treating mucopolysaccharidosis type I or II

Sangamo Therapeutics, Inc. · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10646534

Formulation, preparation method and use of Chinese herbal medicine composition for soothing liver

INFINITUS (CHINA) COMPANY LTD. · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10647689

Apelin receptor agonists and methods of use thereof

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10647715

KRas G12C inhibitors

Mirati Therapeutics, Inc. · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10647661

Carboxamides as modulators of sodium channels

Vertex Pharmaceuticals Incorporated · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10647658

Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same

The Regents of the University of California · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10646591

Imaging agents for imaging protease activity and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)